Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
Cerilliant
Teva
Daiichi Sankyo
Novartis
Moodys
Chinese Patent Office
Federal Trade Commission
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

Doxazosin mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxazosin mesylate and what is the scope of doxazosin mesylate freedom to operate?

Doxazosin mesylate
is the generic ingredient in three branded drugs marketed by Pfizer, Accord Hlthcare, Actavis Elizabeth, Apotex, Dava Pharms Inc, Genpharm, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Pliva, Sandoz, Teva, Watson Labs Inc, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for doxazosin mesylate. Thirty-five suppliers are listed for this compound.

Pharmacology for doxazosin mesylate

Medical Subject Heading (MeSH) Categories for doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Dava Pharms IncDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL076161-002Jun 10, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075509-001Oct 19, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075432-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075646-003Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ApotexDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075580-003Oct 18, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GenpharmDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075466-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerCARDURA XLdoxazosin mesylateTABLET, EXTENDED RELEASE;ORAL021269-001Feb 22, 2005RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075646-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075432-002Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL208719-004Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerCARDURA XLdoxazosin mesylateTABLET, EXTENDED RELEASE;ORAL021269-002Feb 22, 2005► Subscribe► Subscribe
PfizerCARDURAdoxazosin mesylateTABLET;ORAL019668-003Nov 2, 1990► Subscribe► Subscribe
PfizerCARDURAdoxazosin mesylateTABLET;ORAL019668-004Nov 2, 1990► Subscribe► Subscribe
PfizerCARDURAdoxazosin mesylateTABLET;ORAL019668-002Nov 2, 1990► Subscribe► Subscribe
PfizerCARDURAdoxazosin mesylateTABLET;ORAL019668-001Nov 2, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
AstraZeneca
Moodys
Novartis
Chinese Patent Office
Medtronic
Covington
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot